Matthew Paulson

1.3k total citations
18 papers, 1.0k citations indexed

About

Matthew Paulson is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Matthew Paulson has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Matthew Paulson's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Matthew Paulson is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Matthew Paulson collaborates with scholars based in United States, Belgium and Australia. Matthew Paulson's co-authors include David T. Levy, Charles M. Rice, Alice Mui, S N Guadagno, Pan Li, Hans Reiser, Hao-Ming Chang, Isabelle Marié, Bryan Williams and Michelle Holko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.

In The Last Decade

Matthew Paulson

18 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Paulson United States 14 421 399 319 294 273 18 1.0k
Andrew M. Ackrill United Kingdom 13 677 1.6× 696 1.7× 130 0.4× 219 0.7× 255 0.9× 17 1.1k
Kelly A. Wong United States 12 383 0.9× 357 0.9× 379 1.2× 220 0.7× 257 0.9× 20 931
Vicky M.-H. Sung United States 12 1.1k 2.5× 784 2.0× 300 0.9× 204 0.7× 302 1.1× 14 1.6k
Urania Georgopoulou Greece 18 441 1.0× 435 1.1× 397 1.2× 74 0.3× 130 0.5× 55 1.0k
Penelope Mavromara Greece 23 760 1.8× 613 1.5× 425 1.3× 68 0.2× 219 0.8× 68 1.4k
Carl Laxton United Kingdom 11 241 0.6× 292 0.7× 498 1.6× 906 3.1× 909 3.3× 17 1.6k
Myriam Bodescot France 12 357 0.8× 275 0.7× 476 1.5× 591 2.0× 172 0.6× 18 1.3k
Marcello Merola Italy 19 132 0.3× 271 0.7× 298 0.9× 108 0.4× 218 0.8× 44 812
William R. Addison Canada 14 646 1.5× 626 1.6× 379 1.2× 62 0.2× 203 0.7× 24 1.3k
Kazunori Kajino Japan 21 453 1.1× 512 1.3× 447 1.4× 183 0.6× 142 0.5× 70 1.2k

Countries citing papers authored by Matthew Paulson

Since Specialization
Citations

This map shows the geographic impact of Matthew Paulson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Paulson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Paulson more than expected).

Fields of papers citing papers by Matthew Paulson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Paulson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Paulson. The network helps show where Matthew Paulson may publish in the future.

Co-authorship network of co-authors of Matthew Paulson

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Paulson. A scholar is included among the top collaborators of Matthew Paulson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Paulson. Matthew Paulson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xu, Xiaojun, Hong Thai, Kathryn M. Kitrinos, et al.. (2016). Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction. BMC Bioinformatics. 17(S8). 280–280. 8 indexed citations
2.
Younossi, Zobair M., Maria Stepanova, Michael Estep, et al.. (2015). Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin. Journal of Hepatology. 64(1). 29–36. 28 indexed citations
3.
Carlin, Aaron F., Paula Aristizabal, Qinghua Song, et al.. (2015). Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection. Hepatology. 62(4). 1047–1058. 48 indexed citations
4.
Lin, Jennifer, François Habersetzer, M. Rodríguez‐Torres, et al.. (2014). Interferon γ–Induced Protein10 Kinetics in Treatment-Naive Versus Treatment-Experienced Patients Receiving Interferon-Free Therapy for Hepatitis C Virus Infection: Implications for the Innate Immune Response. The Journal of Infectious Diseases. 210(12). 1881–1885. 16 indexed citations
5.
Nelson, David R., Eric M. Yoshida, Matthew Paulson, et al.. (2013). Genome-Wide Association Study to Characterize Serum Bilirubin Elevations in Patients with HCV Treated with Gs-9256, An HCV Ns3 Serine Protease Inhibitor. Antiviral Therapy. 19(7). 679–686. 5 indexed citations
6.
Pokrovskii, Maria, Philip Morganelli, Eda Canales, et al.. (2013). A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity. Antimicrobial Agents and Chemotherapy. 58(1). 386–396. 18 indexed citations
7.
Cheng, Guofeng, Huiling Yang, Maria Pokrovskii, et al.. (2011). Selection of Clinically Relevant Protease Inhibitor-Resistant Viruses Using the Genotype 2a Hepatitis C Virus Infection System. Antimicrobial Agents and Chemotherapy. 55(5). 2197–2205. 16 indexed citations
8.
Pokrovskii, Maria, Rudolf K. Beran, Margaret Robinson, et al.. (2011). Novel Mutations in a Tissue Culture-Adapted Hepatitis C Virus Strain Improve Infectious-Virus Stability and Markedly Enhance Infection Kinetics. Journal of Virology. 85(8). 3978–3985. 29 indexed citations
9.
Cheng, Guofeng, Huiling Yang, Maria Pokrovskii, et al.. (2010). Selection of Clinically-relevant Protease Inhibitor Resistant Viruses using the HCV Infection System. Antiviral Research. 86(1). A19–A19. 1 indexed citations
10.
Paulson, Matthew. (2010). Generation and Quantitation of Infectious Hepatitis C Virus Derived from Cell Culture (HCVcc). Current Protocols in Pharmacology. 51(1). Unit 13B.4–Unit 13B.4. 2 indexed citations
11.
Paulson, Matthew, Huiling Yang, I‐hung Shih, et al.. (2009). Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. Antiviral Research. 83(2). 135–142. 18 indexed citations
12.
Vliegen, Inge, Jan Paeshuyse, Tine De Burghgraeve, et al.. (2009). Substituted imidazopyridines as potent inhibitors of HCV replication. Journal of Hepatology. 50(5). 999–1009. 35 indexed citations
13.
Meuleman, Philip, Joseph Hesselgesser, Matthew Paulson, et al.. (2008). Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology. 48(6). 1761–1768. 177 indexed citations
14.
Hahn, Thomas von, Brett D. Lindenbach, Agnès Boullier, et al.. (2006). Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology. 43(5). 932–942. 100 indexed citations
15.
Tellinghuisen, Timothy L., Matthew Paulson, & Charles M. Rice. (2006). The NS5A Protein of Bovine Viral Diarrhea Virus Contains an Essential Zinc-Binding Site Similar to That of the Hepatitis C Virus NS5A Protein. Journal of Virology. 80(15). 7450–7458. 40 indexed citations
16.
Chang, Hao-Ming, Matthew Paulson, Michelle Holko, et al.. (2004). Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proceedings of the National Academy of Sciences. 101(26). 9578–9583. 179 indexed citations
17.
Paulson, Matthew, et al.. (2002). IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nature Cell Biology. 4(2). 140–147. 103 indexed citations
18.
Paulson, Matthew, et al.. (1999). Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent Sequences. Journal of Biological Chemistry. 274(36). 25343–25349. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew M. Ackrill Breakdown of academic impact, for papers by Kelly A. Wong Breakdown of academic impact, for papers by Vicky M.-H. Sung Breakdown of academic impact, for papers by Urania Georgopoulou Breakdown of academic impact, for papers by Penelope Mavromara Breakdown of academic impact, for papers by Carl Laxton Breakdown of academic impact, for papers by Myriam Bodescot Breakdown of academic impact, for papers by Marcello Merola Breakdown of academic impact, for papers by William R. Addison Breakdown of academic impact, for papers by Kazunori Kajino
Rankless by CCL
2026